NASDAQ : MLTX

MoonLake Immunotherapeutics — Earnings Estimates

$19.02 USD

-$0.34 (-1.76%)

Volume
650.76K
Average Volume
1.11M
Market Capitalization
$1.57B
P/E Ratio
-4.90
Dividend Yield
0.00%
Price Target
$40.00
Year High
$62.75
Year Low
$5.95
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$8.60

Annual earnings financials

MLTX financial data with annual/quarterly toggle

MLTX GAAP EPS - Annual & Quarterly

MLTX Sales Revenue - Annual & Quarterly

MLTX Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

MLTX Estimated and Actual Revenue by Quarter
MLTX Estimated and Actual EPS by Quarter
MLTX Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 1 - - - - - -
2027-09-30 1 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 1 - - - - - -
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
MLTX Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 1 -61.65M -61.65M -61.65M - - -
2027-09-30 1 -69.8M -69.8M -69.8M - - -
2027-06-30 0 -67.22M -67.22M -67.22M - - -
2027-03-31 1 -69.95M -69.95M -69.95M - - -
2026-12-31 0 -64.69M -64.69M -64.69M - - -
2026-09-30 0 -73.84M -52.24M -65.48M - - -
MLTX Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 1 20.97M 20.97M 20.97M 2 -0.86492 -0.86492 -0.86492
2027-09-30 1 4M 4M 4M 2 -0.97937 -0.97937 -0.97937
2027-06-30 0 - - - 2 -0.94307 -0.94307 -0.94307
2027-03-31 1 139.33K 139.33K 139.33K 2 -0.98144 -0.98144 -0.98144
2026-12-31 0 - - - 4 -0.90758 -0.90758 -0.90758
2026-09-30 0 - - - 6 -1.03596 -0.73299 -0.91868